TrialCNS drugs2020

Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study.

Peter J Weiden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.